NCT06709248

Brief Summary

The goal of this observational study is to evaluate the feasibility of the intervention Life Coping Program in children and adolescents 8-16 years of age. The main question it aims to answer is: Is the Life Coping Program in its current form feasible among children and adolescents with a variety of primary conditions? The health care providers of participants already undergoing the Life Coping Program will answer survey questions after key procedures of the intervention, and the research team will be given access to measures provided by the participants.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2023

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

November 25, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 29, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2025

Completed
Last Updated

June 11, 2025

Status Verified

November 1, 2024

Enrollment Period

2.1 years

First QC Date

November 25, 2024

Last Update Submit

June 6, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Proportion of completed components

    The proportion of completed components of the Life Coping Program per participant, as reported on checklists completed by health personnel, fully completed questionnaires by participants, and successful use of activity monitors.

    From enrollment to 6 months after the 5-day Life Coping Course

  • Checklist for health personnel

    Based on the work of Bellg et al. (2004) and Husted et al. (2014), purpose-built checklists are designed for four pre-defined key procedures of the intervention; 1. Primary digital consultation, 2. primary individual consultation during the Life Coping Course, 3. Activities during the Life Coping Course, and 4. The digital follow-up consultation 3-4 weeks after.

    Immediately after the procedures

Secondary Outcomes (4)

  • Evaluation of the Life Coping Course

    Immediately after the procedure

  • Health related Quality of Life

    From enrollment to 3-4 weeks and 6 months after the 5-days Life Coping Course

  • Activity Levels

    From enrollment to 6 months after the 5-days Life Coping Course

  • Self-reported activity levels and satisfaction with relevant activities

    From enrollment to 3-4 weeks and 6 months after the five-day Life Coping Course.

Study Arms (1)

Intervention

EXPERIMENTAL

In this feasability study following established clinical practice, all participants are included in the intervention Life Coping Program.

Behavioral: Life Coping Program

Interventions

The Life Coping Program is built around a coordinated 5-day Life Coping Course. Participants included are grouped by their primary condition, meaning the diagnosis or illness reasoning the referral. Each family is assigned a dedicated Primary Contact throughout the program, and the program consists of three phases: Phase 1: Preparation - Written/visual materials and questionnaires are provided to motivate and inform. A digital consultation occurs 3-5 weeks before the Life Coping Course, covering goals, commitment, and follow-up. Materials are offered in paper or digital formats. Phase 2: Life Coping Course - The 5-day course includes individual consultations, group activities, education, and medical follow-ups, focusing on coping strategies and well-being. Phase 3: Implementation - A summary meeting is conducted, including key persons for further implementation in own local area. Digital follow-ups at 3-4 weeks and 6 months post course assess progress and guide goal achievement.

Intervention

Eligibility Criteria

Age8 Years - 16 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Have received treatment at Haukeland University Hospital
  • One or more of the following primary conditions: congenital heart defects, congenital oral clefts, premature birth before 32 weeks of gestation, completion of cancer treatment, chronic pain conditions, or significant burn injuries
  • Must be able to answer questionnaires in Norwegian

You may not qualify if:

  • Medical condition that may hinder og alter participation
  • Treatment plan that may hinder or alter participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Haukeland university hospital - Department of Pediatrics

Bergen, Vestland, 5009, Norway

Location

Related Publications (1)

  • Bovim LPV, Rotevatn EO, Kvidaland HK, Bogen B, Halvorsen T, Engan M. Feasibility of a group-based intervention to enhance health-related quality of life and physical activity in children and adolescents with chronic illness: a study protocol. Pilot Feasibility Stud. 2025 Jul 17;11(1):101. doi: 10.1186/s40814-025-01682-w.

Related Links

MeSH Terms

Conditions

Motor ActivityPrecursor Cell Lymphoblastic Leukemia-Lymphoma

Condition Hierarchy (Ancestors)

BehaviorLeukemia, LymphoidLeukemiaNeoplasms by Histologic TypeNeoplasmsHematologic DiseasesHemic and Lymphatic DiseasesLymphoproliferative DisordersLymphatic DiseasesImmunoproliferative DisordersImmune System Diseases

Study Officials

  • Mette Engan, MD PhD

    Haukeland University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 25, 2024

First Posted

November 29, 2024

Study Start

May 1, 2023

Primary Completion

May 31, 2025

Study Completion

May 31, 2025

Last Updated

June 11, 2025

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations